ArticleCancers2022

A Combination of Sorafenib, an Immune Checkpoint Inhibitor, TACE and Stereotactic Body Radiation Therapy versus Sorafenib and TACE in Advanced Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombus.

Zeyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.